CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial
Nagamu Inoue, Kiyonori Kobayashi, Makoto Naganuma, Fumihito Hirai, Morio Ozawa, Dilek Arikan, Bidan Huang, Anne M. Robinson, Roopal B. Thakkar, Toshifumi Hibi
Intest Res. 2017;15(3):395-401.   Published online June 12, 2017
DOI: https://doi.org/10.5217/ir.2017.15.3.395

Excel Download

Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial
Intestinal Research. 2017;15(3):395   Crossref logo
Link1 Link2 Link3

Short and long-term efficacy and safety of Adalimumab in children with active Crohn's disease: A prospective, open-label, single-centre trial
Digestive and Liver Disease. 2008;40(10):A51   Crossref logo
Link1 Link2

Adalimumab treatment in Crohn's disease: an overview of long-term efficacy and safety in light of the EXTEND trial
Clinical and Experimental Gastroenterology. 2013;153   Crossref logo
Link1

Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: Results from a phase III open-label extension trial
Epilepsia. 2012;53(3):521-528   Crossref logo
Link1

PP101-MON: Long-Term Safety and Efficacy of Teduglutide Treatment for Intestinal Failure Associated with Short Bowel Syndrome (SBS–IF): Final Results of a 2-Year, Multicenter, Open-Label, Clinical Trial
Clinical Nutrition. 2014;33:S167   Crossref logo
Link1 Link2

OC3.11.2 SHORT-TERM EFFICACY AND SAFETY OF ADALIMUMAB IN CHILDREN WITH ACTIVE CROHN'S DISEASE: A PROSPECTIVE, OPEN LABEL, SINGLE CENTER TRIAL
Digestive and Liver Disease. 2008;40:S68   Crossref logo
Link1 Link2

Prolonged-release melatonin for insomnia – an open-label long-term study of efficacy, safety, and withdrawal
Therapeutics and Clinical Risk Management. 2011;301   Crossref logo
Link1

Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension Trial
Clinical Therapeutics. 2015;37(11):2420-2438   Crossref logo
Link1 Link2

W1247 Short-Term Efficacy and Safety of Adalimumab in Children with Active Crohn's Disease: A Prospective, Open Label, Single Center Trial
Gastroenterology. 2008;134(4):A-664   Crossref logo
Link1 Link2

Phase III safety and efficacy study of long-term brinzolamide/timolol fixed combination in Japanese patients with open-angle glaucoma or ocular hypertension
Clinical Ophthalmology. 2013;149   Crossref logo
Link1